Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 8(1): 10023, 2018 07 03.
Artigo em Inglês | MEDLINE | ID: mdl-29968774

RESUMO

Green tea and its major polyphenol epigallocatechin-3-O-gallate (EGCG) have suppressive effect on dietary obesity. However, it remains unsolved what type of diet on which they exhibit high or low anti-obesity effect. In the present study, we investigated whether anti-obesity effect of green tea differs depending on composition of fats or fatty acids that consist high-fat (HF) diet in mouse model. Green tea extract (GTE) intake dramatically suppressed weight gain and fat accumulation induced by olive oil-based HF diet, whereas the effects on those induced by beef tallow-based HF diet were weak. GTE also effectively suppressed obesity induced by unsaturated fatty acid-enriched HF diet with the stronger effect compared with that induced by saturated fatty acid-enriched HF diet. These differences would be associated with the increasing action of GTE on expression of PPARδ signaling pathway-related genes in the white adipose tissue. Expressions of genes relating to EGCG signaling pathway that is critical for exhibition of physiological effects of EGCG were also associated with the different effects of GTE. Here, we show that anti-obesity effect of GTE differs depending on types of fats or fatty acids that consist HF diet and could be attenuated by saturated fatty acid.


Assuntos
Catequina/análogos & derivados , Ácidos Graxos/efeitos adversos , Obesidade/tratamento farmacológico , Extratos Vegetais/farmacologia , Chá/química , Tecido Adiposo Branco/patologia , Animais , Catequina/farmacologia , Dieta Hiperlipídica , Masculino , Carne/efeitos adversos , Camundongos , Camundongos Endogâmicos C57BL , Azeite de Oliva/efeitos adversos , PPAR gama/metabolismo , Aumento de Peso/efeitos dos fármacos
2.
Biochem Biophys Res Commun ; 450(1): 824-30, 2014 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-24960198

RESUMO

Strictinin has been shown to suppress interleukin (IL)-4-induced signal transducer and activator of transcription (STAT)-6 phosphorylation, which is a critical event for IgE class switching. However, it is unclear how strictinin inhibits STAT6 activation. Strictinin inhibited STAT6 phosphorylation by suppressing IL-4 receptor α (IL-4Rα) activation. Strictinin was bound to the cell surface and only localized in non-lipid raft fraction of the cells where IL-4Rα was also located. In addition, strictinin directly bound to IL-4Rα and inhibited binding of IL-4 to IL-4Rα. These results suggest that IL-4Rα locating in non-lipid raft region is a target molecule for strictinin in inhibiting STAT6 activation.


Assuntos
Interleucina-4/metabolismo , Microdomínios da Membrana/metabolismo , Fenóis/farmacologia , Receptores de Interleucina-4/antagonistas & inibidores , Receptores de Interleucina-4/metabolismo , Fator de Transcrição STAT6/metabolismo , Animais , Linfoma de Burkitt , Células HeLa , Humanos , Camundongos , Células NIH 3T3 , Fosforilação/efeitos dos fármacos , Ativação Transcricional/efeitos dos fármacos
3.
FEBS Lett ; 587(18): 3052-7, 2013 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-23916810

RESUMO

(-)-Epigallocatechin-3-O-gallate (EGCG), a polyphenol in green tea, induces apoptosis in acute myeloid leukemia (AML) cells without affecting normal cells. In this study, we observed that cGMP acts as a cell death mediator of the EGCG-induced anti-AML effect through acid sphingomyelinase activation. EGCG activated the Akt/eNOS axis, a well-known mechanism in vascular cGMP upregulation. We also observed that a major cGMP negative regulator, phosphodiesterase 5, was overexpressed in AML cells, and PDE5 inhibitor, an anti-erectile dysfunction drug, synergistically enhanced the anti-AML effect of EGCG. This combination regimen killed AML cells via overexpressed 67-kDa laminin receptors.


Assuntos
Apoptose/efeitos dos fármacos , Catequina/análogos & derivados , Regulação Leucêmica da Expressão Gênica/efeitos dos fármacos , Inibidores da Fosfodiesterase 5/farmacologia , Receptores de Laminina/genética , Catequina/farmacologia , GMP Cíclico/metabolismo , Nucleotídeo Cíclico Fosfodiesterase do Tipo 5/genética , Nucleotídeo Cíclico Fosfodiesterase do Tipo 5/metabolismo , Sinergismo Farmacológico , Ativação Enzimática/efeitos dos fármacos , Células HL-60 , Humanos , Leucemia Mieloide Aguda/tratamento farmacológico , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/patologia , Óxido Nítrico Sintase Tipo III/genética , Óxido Nítrico Sintase Tipo III/metabolismo , Proteína Oncogênica v-akt/genética , Proteína Oncogênica v-akt/metabolismo , Cultura Primária de Células , Receptores de Laminina/agonistas , Receptores de Laminina/metabolismo , Transdução de Sinais , Esfingomielina Fosfodiesterase/genética , Esfingomielina Fosfodiesterase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA